1. Head and neck cancers version 1,2022
2. Multicenter retrospective study of nivolumab for recurrent/metastatic oral squamous cell carcinoma;Yamakawa;Oral Dis,2022
3. Efficacy and safety of pembrolizumab monotherapy for recurrent/unresectable/metastatic oral squamous cell carcinoma: a single-center study in China;Li;J Oncol,2022
4. Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck;Kacew;Oral Oncol,2020
5. Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma;Pestana;Oral Oncol,2020